Ceftriaxone blocks the polymerization of α-synuclein and exerts neuroprotective effects in vitro - Wikidata - wikimedia - TriplyDB

Ceftriaxone blocks the polymerization of α-synuclein and exerts neuroprotective effects in vitro

Ceftriaxone blocks the polymerization of α-synuclein and exerts neuroprotective effects in vitro

http://www.wikidata.org/entity/Q41877125

about

Purification of bacterial membrane sensor kinases and biophysical methods for determination of their ligand and inhibitor interactions Alpha-synuclein biology in Lewy body diseases Discovery of 3-Arylcoumarin-tetracyclic Tacrine Hybrids as Multifunctional Agents against Parkinson's Disease Modulating the Amyloidogenesis of α-Synuclein Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species.Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson's disease model.α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.Investigational α-synuclein aggregation inhibitors: hope for Parkinson's disease.Pore-Forming Proteins as Mediators of Novel Epigenetic Mechanism of Epilepsy.Effects of Trehalose on Thermodynamic Properties of Alpha-synuclein Revealed through Synchrotron Radiation Circular Dichroism.Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat.Cellular Origin of [18F]FDG-PET Imaging Signals During Ceftriaxone-Stimulated Glutamate Uptake: Astrocytes and Neurons.Characterisation of Conformational and Ligand Binding Properties of Membrane Proteins Using Synchrotron Radiation Circular Dichroism (SRCD).Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies.Ceftriaxone Protects Astrocytes from MPP(+) via Suppression of NF-κB/JNK/c-Jun Signaling.Spectroscopy data of ceftriaxone-lysozyme interaction and computational studies.Modulation of the expression of genes related to the system of amyloid-beta metabolism in the brain as a novel mechanism of ceftriaxone neuroprotective properties.Ceftriaxone Treatment for Neuronal Deficits: A Histological and MEMRI Study in a Rat Model of Dementia with Lewy Bodies

P2860

Q26747190-3777982B-CB9F-4E85-8EC5-6C6BC049E282 Q27003541-FC3BAA8D-CA03-421B-BA7B-F676E25BF8FE Q34310215-F9B2A50C-9246-4A73-A0D2-08C9DE48C014 Q36872325-4D92C087-A2E2-4907-BDA5-F725BB74A45B Q37622863-06B59EFE-37BD-4622-BBF4-5344B0B256AE Q37745115-CC4E9370-78BB-4F37-A34C-19C837E0C0E6 Q38669019-905648C7-DF1D-42F1-A5FD-4DA40D61EAF2 Q38817063-90F9F4AE-5262-4DD2-B2FC-F2447FB4C220 Q39114272-C4574CA8-4C02-4B79-B59A-F549D2213139 Q41196398-1F2EA451-0FF4-4B4F-B300-3C9E7510EDC2 Q41817045-75AD156C-79B0-498C-8DC6-6479EA926DF6 Q47220200-5149D18A-C1AE-4FB5-9954-CF6B9D2A055B Q51188125-F4D4FBFD-3474-484A-A976-C2F85B5C6F43 Q52679169-0C40D7A9-3433-4A08-9010-64C896CF021C Q55071924-15FA5191-FE18-49FE-93F4-3117666A08B8 Q55344980-DEC74B85-6318-4255-A22E-937D698F0D25 Q55346138-055F2093-1398-4A75-8D7F-E96543C88FE6 Q58805879-C145D5ED-9735-4DA1-895C-9DA1583FE9A7

P2860

Ceftriaxone blocks the polymerization of α-synuclein and exerts neuroprotective effects in vitro

http://www.wikidata.org/entity/Q41877125

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Ceftriaxone blocks the polymer ...... uroprotective effects in vitro

@en

type

label

Ceftriaxone blocks the polymer ...... uroprotective effects in vitro

@en

prefLabel

Ceftriaxone blocks the polymer ...... uroprotective effects in vitro

@en

P1433

Q41877125-61297244-6E46-4BFF-99E7-A723126B8EF6

P1476

Q41877125-9CD1FA32-3ED3-4D32-9844-F55A0C729D38

P2093

Q41877125-023D7EEC-A847-4C2E-AA1A-17C2574B5113

Q41877125-46117F5B-8B39-43DE-B726-83DCD259E029

Q41877125-4D4574C7-146C-4EF3-AAA9-6576FDC197E8

Q41877125-65E3B333-B921-4D71-8E3F-81DED68331D3

Q41877125-7DF1ED61-DF38-40EB-BEEC-87541D28B715

Q41877125-8CCFE910-7F1E-4380-A8A1-FC31D96FB43D

Q41877125-A356E81C-E94E-4FA6-8E49-0B5302CD745A

Q41877125-B196DBCD-B2B8-4C06-A6E1-118065EBA628

Q41877125-CE87A4EA-C87A-44E1-B0B8-D863F1214060

Q41877125-FD35E9B5-69A0-4DE3-A913-71DBB7521B1B

P2860

Q41877125-01D22BBC-F580-465E-AE50-5434B1BDFE1A

Q41877125-094A4733-3104-4A79-9BF0-4F9C32767196

Q41877125-0C1D0DD5-56CB-41C7-91F6-C96537A5CA4B

Q41877125-111EA409-4FC2-4C86-899D-DC21DF2D42A2

Q41877125-149E9DD8-4F42-4B35-8593-E22C343E3B25

Q41877125-21AC576F-F653-4CB4-938F-3FB7A4E35BBC

Q41877125-27C28F3F-96DE-4B06-9A0C-288415AD90BA

Q41877125-2A9882F7-8074-46DA-A0EF-6D20011B6AF7

Q41877125-3058B3DA-4887-4A82-BB8B-7D80BF33E921

Q41877125-3D2EED32-F2AC-44D5-8D4E-42D29169F795

P304

Q41877125-769B8022-4D21-4D7E-BA1D-5F4B6BF716EF

P31

Q41877125-B6A8251F-50DA-49EE-A69A-650C3352BD9E

P356

Q41877125-5F9CAE5D-654D-4234-959E-BD6CFB073AE3

P433

Q41877125-E6AA8A1C-0D60-4237-A826-50E7BA08546C

P478

Q41877125-2AE2ABF4-28E0-46D4-9FE6-0FE65CDCE9E2

P50

Q41877125-0DE62722-4DD9-4216-B31F-3F22F82AA20B

Q41877125-83017B36-BAA3-4AC4-A820-71D172D1E4C2

Q41877125-D0091BB2-9E13-4A28-A842-24DF4680692A

Q41877125-F7FD09F8-ED9A-4F6C-BF23-BC95191C07F5

Q41877125-FA231E2F-94C5-4637-8AF8-ED17759824C4

P577

Q41877125-6AC257A1-35A3-4D04-AD4C-39C508A79914

P5875

Q41877125-01D5B3A1-9BEB-42B2-8A65-2474222B14B2

P698

Q41877125-A129DA45-7ED6-4C39-B74D-D80A8454E3A3

P921

Q41877125-558F5BCF-14BE-4A5B-8A4A-8B419F05C186

P932

Q41877125-18160377-AF8F-41BF-ACAE-41AF5800FDA6

P356

P1433

ACS Chemical Neuroscience

P1476

Ceftriaxone blocks the polymer ...... uroprotective effects in vitro

@en

P2093

Anna Marchiani

http://www.w3.org/2001/XMLSchema#string

Davide Fabbri

http://www.w3.org/2001/XMLSchema#string

GianPietro Sechi

http://www.w3.org/2001/XMLSchema#string

Giovanna Delogu

http://www.w3.org/2001/XMLSchema#string

Giuliano Siligardi

http://www.w3.org/2001/XMLSchema#string

Maria A Dettori

http://www.w3.org/2001/XMLSchema#string

Mario Sechi

http://www.w3.org/2001/XMLSchema#string

Mehmet Islami

http://www.w3.org/2001/XMLSchema#string

Rohanah Hussain

http://www.w3.org/2001/XMLSchema#string

Ylenia Spissu

http://www.w3.org/2001/XMLSchema#string

P2860

α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation

Using circular dichroism spectra to estimate protein secondary structure

Alpha-synuclein in Lewy bodies

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice

Ceftriaxone for Alexander's Disease: A Four-Year Follow-Up.

Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases

Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein

Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease.

Structure and dynamics of micelle-bound human alpha-synuclein.

Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

P304

30-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/CN400149K

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Pier Andrea Serra

Rossana Migheli

P577

2013-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257529714

http://www.w3.org/2001/XMLSchema#string

P698

24099687

http://www.w3.org/2001/XMLSchema#string

P921

P932

3894726

http://www.w3.org/2001/XMLSchema#string